MRLOX
Price
$17.10
Change
-$0.30 (-1.72%)
Updated
Mar 10 closing price
Net Assets
16.06B
RLEFX
Price
$34.06
Change
-$0.59 (-1.70%)
Updated
Mar 10 closing price
Net Assets
237.28B
Ad is loading...

MRLOX vs RLEFX

Header iconMRLOX vs RLEFX Comparison
Open Charts MRLOX vs RLEFXBanner chart's image
BlackRock Global Allocation R
Price$17.10
Change-$0.30 (-1.72%)
VolumeN/A
Net Assets16.06B
American Funds American Balanced R5E
Price$34.06
Change-$0.59 (-1.70%)
VolumeN/A
Net Assets237.28B
MRLOX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MRLOX vs. RLEFX commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRLOX is a Hold and RLEFX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 237B vs. MRLOX (16.1B). RLEFX pays higher dividends than MRLOX: RLEFX (2.10) vs MRLOX (0.93). MRLOX was incepted earlier than RLEFX: MRLOX (22 years) vs RLEFX (9 years). MRLOX (1.49) is less costly to investors than RLEFX (0.40). MRLOX (173.00) and RLEFX (171.00) have comparable annual turnover. MRLOX has a lower initial minimum investment than RLEFX: MRLOX (100) vs RLEFX (250). RLEFX annual gain was more profitable for investors over the last year : 5.36 vs. MRLOX (-1.39). RLEFX return over 5 years is better than : 35.62 vs. MRLOX (1.37).
MRLOXRLEFXMRLOX / RLEFX
Total Expense Ratio1.460.40365%
Annual Report Gross Expense Ratio1.490.40372%
Fund Existence22 years9 years-
Gain YTD1.2811.020125%
Front LoadN/AN/A-
Min. Initial Investment10025040%
Min. Initial Investment IRAN/AN/A-
Net Assets16.1B237B7%
Annual Yield % from dividends0.932.1044%
Returns for 1 year-1.395.36-26%
Returns for 3 years1.6217.819%
Returns for 5 years1.3735.624%
Returns for 10 years-4.85N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEON8.390.60
+7.70%
Neonode
IART23.000.97
+4.40%
Integra LifeSciences Holdings Corp
MITK9.100.06
+0.66%
Mitek Systems
DRMA1.21N/A
N/A
Dermata Therapeutics Inc.
DT52.21-1.37
-2.56%
Dynatrace